A mutation found in LHCGR, STON1-GTF2A1L (luteinizing hormone/choriogonadotropin receptor| STON1-GTF2A1L readthrough) on Chromosome 2 may be clinically relevant. Is it pathogenic or benign, and if the former, which disease is implicated?
Pathogenic; Luteinizing hormone resistance, female